ProShare Advisors’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,321
| Closed | -$274K | – | 2272 |
|
|
2024
Q3 | $274K | Sell |
4,321
-327
| -7% | -$23.6K | ﹤0.01% | 1525 |
|
|
2024
Q2 | $314K | Sell |
4,648
-14
| -0.3% | -$978 | ﹤0.01% | 1261 |
|
|
2024
Q1 | $369K | Sell |
4,662
-374
| -7% | -$30.6K | ﹤0.01% | 1283 |
|
|
2023
Q4 | $392K | Sell |
5,036
-55
| -1% | -$4.07K | ﹤0.01% | 1200 |
|
|
2023
Q3 | $358K | Sell |
5,091
-410
| -7% | -$30.6K | ﹤0.01% | 1112 |
|
|
2023
Q2 | $438K | Sell |
5,501
-158
| -3% | -$11.4K | ﹤0.01% | 1029 |
|
|
2023
Q1 | $409K | Sell |
5,659
-1,324
| -19% | -$103K | ﹤0.01% | 1007 |
|
|
2022
Q4 | $575K | Buy |
6,983
+574
| +9% | +$47.3K | ﹤0.01% | 896 |
|
|
2022
Q3 | $501K | Sell |
6,409
-49
| -0.8% | -$3.92K | ﹤0.01% | 894 |
|
|
2022
Q2 | $437K | Sell |
6,458
-2,503
| -28% | -$175K | ﹤0.01% | 994 |
|
|
2022
Q1 | $588K | Sell |
8,961
-1,426
| -14% | -$82.8K | ﹤0.01% | 1176 |
|
|
2021
Q4 | $631K | Buy |
10,387
+2,037
| +24% | +$121K | ﹤0.01% | 1301 |
|
|
2021
Q3 | $533K | Sell |
8,350
-1,690
| -17% | -$107K | ﹤0.01% | 1173 |
|
|
2021
Q2 | $630K | Buy |
10,040
+1,500
| +18% | +$94.1K | ﹤0.01% | 1363 |
|
|
2021
Q1 | $488K | Sell |
8,540
-55
| -0.6% | -$2.98K | ﹤0.01% | 1456 |
|
|
2020
Q4 | $432K | Buy |
8,595
+1,026
| +14% | +$40.9K | ﹤0.01% | 1360 |
|
|
2020
Q3 | $223K | Buy |
+7,569
| New | +$220K | ﹤0.01% | 1357 |
|
|
2020
Q1 | – | Sell |
-9,654
| Closed | -$321K | – | 1162 |
|
|
2019
Q4 | $321K | Buy |
9,654
+872
| +10% | +$27.3K | ﹤0.01% | 1298 |
|
|
2019
Q3 | $273K | Sell |
8,782
-469
| -5% | -$14.3K | ﹤0.01% | 1274 |
|
|
2019
Q2 | $323K | Sell |
9,251
-1,672
| -15% | -$54.1K | ﹤0.01% | 1203 |
|
|
2019
Q1 | $320K | Buy |
10,923
+2,437
| +29% | +$69K | ﹤0.01% | 1218 |
|
|
2018
Q4 | $218K | Sell |
8,486
-1,960
| -19% | -$67.8K | ﹤0.01% | 1328 |
|
|
2018
Q3 | $368K | Buy |
10,446
+1,456
| +16% | +$58K | ﹤0.01% | 1252 |
|
|
2018
Q2 | $368K | Sell |
8,990
-51
| -0.6% | -$2.06K | ﹤0.01% | 1265 |
|
|
2018
Q1 | $354K | Sell |
9,041
-215
| -2% | -$7.88K | ﹤0.01% | 1250 |
|
|
2017
Q4 | $302K | Buy |
9,256
+2,105
| +29% | +$72.9K | ﹤0.01% | 1381 |
|
|
2017
Q3 | $342K | Buy |
7,151
+274
| +4% | +$13.4K | ﹤0.01% | 1091 |
|
|
2017
Q2 | $340K | Buy |
+6,877
| New | +$305K | ﹤0.01% | 1106 |
|
|
2015
Q3 | – | Sell |
-2,966
| Closed | -$232K | – | 1448 |
|
|
2015
Q2 | $232K | Sell |
2,966
-7,902
| -73% | -$569K | ﹤0.01% | 1427 |
|
|
2015
Q1 | $778K | Sell |
10,868
-645
| -6% | -$41.4K | 0.01% | 975 |
|
|
2014
Q4 | $705K | Sell |
11,513
-6,930
| -38% | -$403K | 0.01% | 1037 |
|
|
2014
Q3 | $894K | Buy |
18,443
+722
| +4% | +$35.3K | 0.01% | 1112 |
|
|
2014
Q2 | $806K | Sell |
17,721
-18,139
| -51% | -$797K | 0.01% | 1267 |
|
|
2014
Q1 | $1.62M | Buy |
+35,860
| New | +$1.77M | 0.02% | 905 |
|
|
2013
Q4 | – | Sell |
-22,373
| Closed | -$882K | – | 1336 |
|
|
2013
Q3 | $882K | Buy |
22,373
+4,823
| +27% | +$179K | 0.02% | 968 |
|
|
2013
Q2 | $580K | Buy |
+17,550
| New | +$570K | 0.01% | 1213 |
|
Other funds holding ACHC
PCP
MAP
ProShare Advisors's ACHC Position: Q4 2024 in Review
ProShare Advisors sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 4,321 shares — an estimated $274K sold.
ProShare Advisors first reported a position in ACHC in Q2 2013 and held it in 36 quarters. The position peaked at $1.62M in Q1 2014. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.
- ProShare Advisors reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
- ProShare Advisors sold 4,321 Acadia Healthcare shares in Q4 2024, an estimated $274K.
- ProShare Advisors first reported a position in Acadia Healthcare in Q2 2013 and held it in 36 quarters.
- ProShare Advisors's Acadia Healthcare position peaked at $1.62M in Q1 2014.
- 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.
Based on ProShare Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.